{"schema_version":"1","generated_at":"2026-11-06T13:25:10.545Z","data_as_of":null,"url":"https://www.findmykol.com/kol/natalia-neparidze","json_url":"https://www.findmykol.com/kol/natalia-neparidze/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"natalia-neparidze","name":"Natalia Neparidze","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Yale University","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1649427188","orcid":"0000-0001-9038-077X","openalex":"A5055262015"},"summary":"Natalia Neparidze is a Hematology physician affiliated with Yale University. OpenAlex indexes 131 publications with 2,608 citations (h-index 18); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":131,"cited_by_count":2608,"h_index":18,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06169215","title":"Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT06169215","trial_url":"https://www.findmykol.com/trial/NCT06169215"},{"nct":"NCT05002816","title":"Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT05002816","trial_url":"https://www.findmykol.com/trial/NCT05002816"},{"nct":"NCT03375567","title":"Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT03375567","trial_url":"https://www.findmykol.com/trial/NCT03375567"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":29,"shown":3,"withheld":26,"rows":[{"payer":"GSK","program_year":2025,"amount_usd":517456,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649427188"},{"payer":"Janssen","program_year":2025,"amount_usd":190976.32,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649427188"},{"payer":"National Marrow Donor Program","program_year":2025,"amount_usd":30610,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1649427188"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1649427188","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024027962","status":"verified"},{"title":"Racial differences in treatment and survival among older patients with multiple myeloma","year":2024,"journal":"Cancer Medicine","source_url":"https://doi.org/10.1002/cam4.6915","status":"verified"},{"title":"Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review","year":2024,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2024.12.006","status":"verified"},{"title":"Patient Perspectives on Social and Identity Factors Affecting Multiple Myeloma Care: Barriers and Opportunities","year":2024,"journal":"Healthcare","source_url":"https://doi.org/10.3390/healthcare12161587","status":"verified"},{"title":"Impact of Social Needs and Identity Experiences on the Burden of Illness in Patients with Multiple Myeloma: A Mixed-Methods Study","year":2024,"journal":"Healthcare","source_url":"https://doi.org/10.3390/healthcare12161660","status":"verified"}],"source":"works"},"contact":{"address_1":"333 CEDAR ST","address_2":"WWW403","city":"New Haven","state":"CT","zip":"065103206","phone":"203-785-4144","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1649427188","source":"identity"},"similar":[{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"},{"name":"Lajos Pusztai","slug":"lajos-pusztai","institution":"Yale University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/lajos-pusztai","json_url":"https://www.findmykol.com/kol/lajos-pusztai/profile.json"},{"name":"Lee Schwamm","slug":"lee-schwamm","institution":"Yale University","specialty":"Neurology","url":"https://www.findmykol.com/kol/lee-schwamm","json_url":"https://www.findmykol.com/kol/lee-schwamm/profile.json"},{"name":"Thomas McGlashan","slug":"thomas-mcglashan","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/thomas-mcglashan","json_url":"https://www.findmykol.com/kol/thomas-mcglashan/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":26,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-06-21","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}